New Advancement Toward The First Primary Endpoint Qualification Of A Digital Endpoint For Duchenne

Current methods for assessing ambulatory function in patients with Duchenne muscular dystrophy do not fully reflect how they experience DMD in their...

Related Keywords

Louvain ,Region Flamande ,Belgium ,Brussels ,Bruxelles Capitale ,Switzerland ,Paris ,France General ,France ,Romania ,Robert Debr ,Roxana Donisa Dreghici ,Laurent Servais ,Carl Morris ,Donisa Dreghici ,Head Of Clinical Development ,Louvain Medical School ,Novo Nordisk ,Franklin Pierce College ,Novartis ,University Of Medicine ,Department Of Physiology ,European Medicines Agency ,Institute Of Myology ,Neuromuscular Centre In Li ,Morris ,Institute Of Muscle ,World Muscle Society ,University Of Pennsylvania ,Research Unit ,Patient Centricity In Duchenne Therapeutic Development ,Free University Of Brussels ,Boston University School Of Medicine ,International Hybrid Annual Congress ,Pfizer Rare Disease Research Unit ,World Muscle Society Congress ,Oxford Neuromuscular Centre ,Senior Vice President ,Clinical Development ,Solid Biosciences ,Chief Scientific Officer ,Paediatric Neuromuscular Diseases ,Neuromuscular Centre ,Invited Professor ,Child Neurology ,Minute Walk Test ,North Star Ambulatory Assessment ,Stride Velocity ,Novel Endpoint For ,World Muscle ,Muscle Society Congress ,Rare Disease Research Unit ,Boston University School ,Aging Research ,Muscle Oriented Translational ,Free University ,